Company / CapEx per Share
Arcutis Biotherapeutics, Inc. CapEx per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.01
FY2025
5-year range
$0.00 / $0.02
FY2021-FY2025
Trend
+294.0%
vs FY2024
Sector context
#137 of 192
Health Care
What the data says
CapEx per Share changed +294% YoY in FY2025, a notable deviation from the 6-year average annual change of +30%.
Based on SEC 10-K filings.
0.01 in FY2025 with a 5-year CAGR of -8.3%.
Declined from $0.01 to $0.01 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -1.3%
- 5-Year CAGR
- -8.3%
- 10-Year CAGR
- -
Sector benchmark
#137 of 192 in Health CareTop 71% of 192This company $0.01 Sector average $2.46
▼
-99.8% below sector average
Key checks
Key Insights
- In FY2025, capex per share increased 294.0% year-over-year.
- Ranks #137 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2019.
- Lowest capex per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | +294.0% |
| FY2024 | $0.00 | -76.1% |
| FY2023 | $0.01 | +2.1% |
| FY2022 | $0.01 | -70.0% |
| FY2021 | $0.02 | +123.8% |
| FY2020 | $0.01 | -94.4% |
| FY2019 | $0.16 | - |
| FY2018 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026